100% Quality Guarantee
PhD-Level Technical Support
Key Features

Lacnotuzumab Biosimilar (M-CSF) Antibody (HDBS0091)

SKU HDBS0091
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein M-CSF
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Lacnotuzumab Biosimilar (M-CSF) Antibody (HDBS0091)

The Lacnotuzumab Biosimilar M-CSF Antibody available at Assay Genie is a cutting-edge product designed for research involving the M-CSF protein, a key regulator of the growth and differentiation of monocytes and macrophages. This antibody, derived from a biosimilar source, is highly specific and sensitive in detecting M-CSF in human samples, making it an invaluable tool for studying immune responses and inflammatory processes.The M-CSF protein plays a crucial role in immune system function by promoting the development and activation of macrophages, which are essential for immune defense and tissue repair. Dysregulation of M-CSF signaling has been implicated in various diseases, including cancer, arthritis, and osteoporosis, making it a promising target for therapeutic interventions.

Researchers can utilize this antibody to study the expression and function of M-CSF in different cell types, offering insights into disease mechanisms and potential treatment strategies.With its high reactivity and specificity, the Lacnotuzumab Biosimilar Anti-M-CSF Antibody is a valuable tool for investigating the role of M-CSF in health and disease. Its application in various research settings, from immunology to oncology, makes it a versatile reagent for advancing our understanding of immune regulation and developing novel therapies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose